Protea Biosciences Group Inc (PRGBQ) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
1311 PINEVIEW DRIVE MORGANTOWN, WV 26505 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 6/30/2017 Q2 | 3/31/2017 Q1 | 12/31/2016 Q4 | 9/30/2016 Q3 | 6/30/2016 Q2 | 3/31/2016 Q1 | 12/31/2015 Q4 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 16 | 79 | 174 | 6 | |||||
| Cash and cash equivalents | 16 | 79 | 174 | 6 | |||||
| Receivables | 89 | 437 | 340 | 375 | 318 | 196 | |||
| Inventory, net of allowances, customer advances and progress billings | 41 | 92 | 146 | 147 | 103 | 111 | |||
| Inventory | 41 | 92 | 146 | 147 | 103 | 111 | |||
| Prepaid expense | 151 | 121 | 71 | 122 | 43 | 98 | |||
| Total current assets: | 296 | 729 | 556 | 818 | 464 | 412 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 2,339 | 2,466 | 2,758 | 2,847 | 2,450 | 2,627 | |||
| Other noncurrent assets | 19 | 19 | 19 | 5 | 5 | 5 | |||
| Total noncurrent assets: | 2,358 | 2,485 | 2,777 | 2,852 | 2,455 | 2,632 | |||
| TOTAL ASSETS: | 2,654 | 3,214 | 3,333 | 3,670 | 2,919 | 3,044 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 2,239 | 494 | 2,316 | 1,674 | 1,648 | 295 | |||
| Interest and dividends payable | 304 | 265 | 117 | 192 | 127 | 109 | |||
| Taxes payable | 0 | 1 | |||||||
| Employee-related liabilities | 189 | 120 | 149 | 148 | 155 | 124 | |||
| Accounts payable | 1,712 | 41 | 1,891 | 1,299 | 1,279 | 33 | |||
| Accrued liabilities | 33 | 68 | 159 | 35 | 87 | 28 | |||
| Debt | 3,798 | 4,012 | 4,319 | 3,636 | 2,076 | 1,324 | |||
| Other liabilities | 551 | 508 | |||||||
| Deferred revenue and credits | 56 | 58 | 72 | 68 | 100 | 80 | |||
| Due to related parties | 1,191 | 3,088 | 2,710 | 2,677 | 2,627 | 2,575 | |||
| Other undisclosed current liabilities | 9,959 | 7,898 | 7,433 | 1,048 | 4,035 | 5,318 | |||
| Total current liabilities: | 17,244 | 15,550 | 17,402 | 9,610 | 10,486 | 9,590 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation, including: | 1,834 | 1,769 | 1,838 | 1,919 | 1,613 | 1,726 | |||
| Long-term debt, excluding current maturities | 3,000 | ||||||||
| Other undisclosed long-term debt and lease obligation | 1,834 | 1,769 | 1,838 | (1,081) | 1,613 | 1,726 | |||
| Other undisclosed noncurrent liabilities | 3,000 | ||||||||
| Total noncurrent liabilities: | 1,834 | 1,769 | 1,838 | 4,919 | 1,613 | 1,726 | |||
| Total liabilities: | 19,078 | 17,320 | 19,239 | 14,528 | 12,099 | 11,316 | |||
| Equity | |||||||||
| Equity, attributable to parent | (16,424) | (14,106) | (15,906) | (10,859) | (9,180) | (8,273) | |||
| Common stock | 21 | 16 | 13 | 13 | 13 | 13 | |||
| Additional paid in capital | 84,665 | 81,123 | 72,089 | 71,619 | 71,489 | 71,312 | |||
| Accumulated other comprehensive income (loss) | 0 | 0 | 0 | (0) | 0 | 0 | |||
| Accumulated deficit | (101,110) | (95,246) | (88,009) | (82,491) | (80,683) | (79,598) | |||
| Total equity: | (16,424) | (14,106) | (15,906) | (10,859) | (9,180) | (8,273) | |||
| TOTAL LIABILITIES AND EQUITY: | 2,654 | 3,214 | 3,333 | 3,670 | 2,919 | 3,044 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 6/30/2017 Q2 | 3/31/2017 Q1 | 12/31/2016 Q4 | 9/30/2016 Q3 | 6/30/2016 Q2 | 3/31/2016 Q1 | 12/31/2015 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues (Revenue, Net) | 355 | 870 | 520 | 582 | 475 | 625 | ||
| Cost of revenue | (287) | (543) | (469) | (490) | (204) | (210) | ||
| Gross profit: | 67 | 327 | 51 | 92 | 271 | 414 | ||
| Operating expenses | (1,626) | (1,324) | (1,546) | (1,528) | (1,837) | (1,636) | ||
| Other undisclosed operating loss | (377) | |||||||
| Operating loss: | (1,559) | (997) | (1,495) | (1,435) | (1,566) | (1,599) | ||
| Nonoperating income (expense) | (4,306) | (6,240) | (4,023) | (372) | 481 | (396) | ||
| Interest and debt expense | (5) | (481) | (963) | (373) | (150) | 1,155 | ||
| Loss from continuing operations before equity method investments, income taxes: | (5,870) | (7,718) | (6,481) | (2,181) | (1,236) | (840) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | 5 | 481 | 963 | 373 | 150 | (1,155) | ||
| Loss from continuing operations: | (5,865) | (7,237) | (5,518) | (1,808) | (1,086) | (1,995) | ||
| Loss before gain (loss) on sale of properties: | (5,865) | (7,237) | (5,518) | (1,808) | (1,086) | (1,995) | ||
| Net loss available to common stockholders, diluted: | (5,865) | (7,237) | (5,518) | (1,808) | (1,086) | (1,995) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 6/30/2017 Q2 | 3/31/2017 Q1 | 12/31/2016 Q4 | 9/30/2016 Q3 | 6/30/2016 Q2 | 3/31/2016 Q1 | 12/31/2015 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (5,865) | (7,237) | (5,518) | (1,808) | (1,086) | (1,995) | ||
| Comprehensive loss: | (5,865) | (7,237) | (5,518) | (1,808) | (1,086) | (1,995) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 0 | 0 | (0) | 0 | 0 | |||
| Comprehensive loss, net of tax, attributable to parent: | (5,865) | (7,237) | (5,518) | (1,808) | (1,085) | (1,995) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.